ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Demand for affordable Indian generic vaccines skyrocket in China

Demand for affordable Indian generic vaccines skyrocket in China

Amid the resurgence in Covid cases, China's indigenous vaccines, "CanSino" and "BBIBPCorV," were heavily scrutinized...

      
      Keomi Beauty targets new product launches in 2023

Keomi Beauty targets new product launches in 2023

New Delhi [India], February 1 (ANI/SRV): Inspired by Japanese beauty secrets, Keomi Beauty recently kick-started its...

      
      Cervavac vaccine will help prevent Cervical: Jitendra Singh

Cervavac vaccine will help prevent Cervical: Jitendra Singh

Serum Institute of India Director Prakash Kumar Singh on Thursday presented Made in India HPV Vaccine Cervavac to...

      
      China needs good Covid 19 booster like Covovax: Adar Poonawala

China needs good Covid 19 booster like Covovax: Adar Poonawala

China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from...

"HPV vaccine to be available in large quantity from next year"

Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number...


      
      Serum Institute of India launches HPV vaccine

Serum Institute of India launches HPV vaccine

The indigenously developed vaccine, "CERVAVAC" was announced for the prevention of cervical cancer.

      
      DGCI approves market authorisation of Covovax as booster dose

DGCI approves market authorisation of Covovax as booster dose

This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.

      
      DCGI recommends Covovax as heterologous booster dose

DCGI recommends Covovax as heterologous booster dose

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market...


      
      Covovax to get booster dose approval in 10-15 days: SII CEO

Covovax to get booster dose approval in 10-15 days: SII CEO

Serum Institute of India CEO Adar Poonawalla on Monday said that the Covovax vaccine will get approval as a booster...

      
      Covid situation in India better: SII CEO Adar Poonawalla

Covid situation in India better: SII CEO Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying...


      
      Rising COVID cases news from China is concerning: SII CEO

Rising COVID cases news from China is concerning: SII CEO

Adar Poonawala also urged the people to adhere to the guidelines set by the Government of India and the Ministry...


      
      'HPV vaccine to prevent cervical cancer could be in India soon'

'HPV vaccine to prevent cervical cancer could be in India soon'

The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.